Tygh Capital Management, Inc. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 270 filers reported holding NOVOCURE LTD in Q1 2020. The put-call ratio across all filers is 1.44 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tygh Capital Management, Inc. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2020$3,475,000
+33.7%
51,600
+67.3%
0.78%
+81.6%
Q4 2019$2,599,000
-39.3%
30,847
-75.9%
0.43%
-52.2%
Q4 2018$4,285,000
-61.9%
127,973
-40.3%
0.90%
-51.1%
Q3 2018$11,236,000
+43.2%
214,431
-14.5%
1.84%
+38.2%
Q2 2018$7,849,000250,7691.33%
Other shareholders
NOVOCURE LTD shareholders Q1 2020
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders